Cargando…
Identification and Characterization of Neoantigens As Well As Respective Immune Responses in Cancer Patients
Cancer immunotherapy has recently emerged as a powerful tool for the treatment of diverse advanced malignancies. In particular, therapeutic application of immune checkpoint modulators, such as anti-CTLA4 or anti-PD-1/PD-L1 antibodies, have shown efficacy in a broad range of malignant diseases. Altho...
Autores principales: | Bräunlein, Eva, Krackhardt, Angela M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5714868/ https://www.ncbi.nlm.nih.gov/pubmed/29250075 http://dx.doi.org/10.3389/fimmu.2017.01702 |
Ejemplares similares
-
Determinants for Neoantigen Identification
por: Garcia-Garijo, Andrea, et al.
Publicado: (2019) -
Neoantigens Generated by Individual Mutations and Their Role in Cancer Immunity and Immunotherapy
por: Efremova, Mirjana, et al.
Publicado: (2017) -
Improvement of Neoantigen Identification Through Convolution Neural Network
por: Hao, Qing, et al.
Publicado: (2021) -
Prognostic Value of Neoantigen Load in Immune Checkpoint Inhibitor Therapy for Cancer
por: Zou, Xue-lin, et al.
Publicado: (2021) -
Structure Based Prediction of Neoantigen Immunogenicity
por: Riley, Timothy P., et al.
Publicado: (2019)